Emerald Advisers’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.8M | Buy |
837,549
+11,074
| +1% | +$327K | 0.91% | 38 |
|
|
2025
Q1 | $24.7M | Buy |
826,475
+14,795
| +2% | +$442K | 1.11% | 35 |
|
|
2024
Q4 | $23.3M | Sell |
811,680
-15,622
| -2% | -$448K | 0.9% | 43 |
|
|
2024
Q3 | $32M | Buy |
827,302
+177,129
| +27% | +$6.84M | 1.24% | 24 |
|
|
2024
Q2 | $20.9M | Sell |
650,173
-19,339
| -3% | -$623K | 0.88% | 46 |
|
|
2024
Q1 | $26M | Buy |
669,512
+3,416
| +0.5% | +$133K | 1.05% | 33 |
|
|
2023
Q4 | $20.5M | Sell |
666,096
-24,391
| -4% | -$751K | 0.88% | 45 |
|
|
2023
Q3 | $15.4M | Sell |
690,487
-114,303
| -14% | -$2.55M | 0.75% | 56 |
|
|
2023
Q2 | $17.3M | Buy |
804,790
+1,654
| +0.2% | +$35.5K | 0.76% | 62 |
|
|
2023
Q1 | $19.3M | Sell |
803,136
-10,553
| -1% | -$253K | 0.92% | 42 |
|
|
2022
Q4 | $18.9M | Sell |
813,689
-3,460
| -0.4% | -$80.3K | 0.91% | 48 |
|
|
2022
Q3 | $13.1M | Buy |
817,149
+4,671
| +0.6% | +$74.8K | 0.68% | 67 |
|
|
2022
Q2 | $14.4M | Buy |
812,478
+12,360
| +2% | +$219K | 0.74% | 55 |
|
|
2022
Q1 | $16.3M | Buy |
800,118
+225,281
| +39% | +$4.59M | 0.62% | 67 |
|
|
2021
Q4 | $10.7M | Sell |
574,837
-15,419
| -3% | -$288K | 0.4% | 92 |
|
|
2021
Q3 | $11.7M | Sell |
590,256
-151,022
| -20% | -$2.98M | 0.42% | 90 |
|
|
2021
Q2 | $17.5M | Sell |
741,278
-7,660
| -1% | -$181K | 0.64% | 71 |
|
|
2021
Q1 | $17.8M | Sell |
748,938
-86,704
| -10% | -$2.05M | 0.64% | 76 |
|
|
2020
Q4 | $16.7M | Buy |
835,642
+122,279
| +17% | +$2.45M | 0.56% | 82 |
|
|
2020
Q3 | $14.9M | Buy |
713,363
+135,050
| +23% | +$2.81M | 0.61% | 68 |
|
|
2020
Q2 | $10.1M | Sell |
578,313
-187,517
| -24% | -$3.28M | 0.44% | 85 |
|
|
2020
Q1 | $12.5M | Sell |
765,830
-14,990
| -2% | -$245K | 0.72% | 51 |
|
|
2019
Q4 | $16.1M | Buy |
+780,820
| New | +$16.1M | 0.68% | 58 |
|